HoldingsChannel.com
Caladrius Biosciences insider buying image
The table below summarizes the most recent Caladrius Biosciences insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Caladrius Biosciences insider buys are important for investors to follow.
DateInsiderPriceAmount
12-8-2021
Insider Buy
Steven S. Myers
Director
$0.89
CAGR »
$30,190.28
33,785 shares
9-9-2020
Insider Buy
Michael H. Davidson
Director
$1.80
CAGR »
$99,945.00
55,525 shares
8-17-2015
Insider Buy
David J. Mazzo
Chief Executive Officer
$1.40
CAGR »
$27,922.00
20,000 shares
8-12-2015
Insider Buy
Robert S. Vaters
President & CFO
$1.35
CAGR »
$16,681.36
12,385 shares
8-11-2015
Insider Buy
Robert S. Vaters
President & CFO
$1.24
CAGR »
$100,172.70
81,000 shares

Also See: Institutional Holders of CLBS
Also See: SEC filings

CLBS Performance Since Insider Purchase
Below we present the annualized performance delivered by Caladrius Biosciences stock since 12-8-2021 (the date of the most recent insider purchase). The performance of the investment from the time Caladrius Biosciences insider buying occurred is the ultimate test of whether insiders were right about CLBS being a good buy.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/09/2021
End date: 09/14/2022
Start price/share: $0.90
End price/share: $0.43
Dividends collected/share: $0.00
Total return: -52.22%
Annualized Gain: -68.57%
Starting investment: $10,000.00
Ending investment: $4,778.00
Years: 0.76

Caladrius Biosciences Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Caladrius Biosciences insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding CLBS

Quotes delayed 20 minutes

Email EnvelopeFree CLBS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Caladrius Biosciences Insider Buying | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.